申请人:Schering Corporation
公开号:US05750532A1
公开(公告)日:1998-05-12
The disclosed invention is compounds represented by the formula ##STR1## and pharmacetically acceptable acid salts thereof, wherein each Z is independently tetiary butyl, phenyl, naphthyl or adamantyl; substituted phenyl, wherein the substituents are one or more of halogen, lower alkoxy, phenoxy, nitrile, nitro, phenylsulfonyl, loweralkyl-sulfonyl, oxazol-2-yl, lower alkanoyl, benzoyl, lower alkoxycarbonyl, lower alkyl, lower alkylthio, phenyl, phenylaminothiocarbonyl, or lower alkylaminothiocarbonyl, hydroxyiminoloweralkyl hydroxyloweralkyl or carbonyl; or 4 or 6 membered unsubstituted or substituted heterocyclic ring containing at least one nitrogen with the remaining member of the ring being at least one carbon, and optionally sulfur or oxygen, X and Y are each independently a bond, ##STR2## each Q is independently a divalent substituted or unsubstituted, straight or branched chain lower alkanediyl, lower alkanediyl-cycloalkanediyl-lower alkanediyl, lower alkenediyl, lower alkynediyl, phenylene, dihydrofurandiyl, loweralkanediyl-dihydrofurandiyl-loweralkanediyl, tetrahydrofurandiyl, tetrahydropyrandiyl, loweralkanediyl-tetrahydropyrandiyl-loweralkanediyl or, loweralkanediyl-tetrahydrofurandiyl-loweralkanediyl; W is a monovalent substituted or unsubstituted aryl group or a heterocyclic single or fused ring containing from 4 to 10 ring atoms, at least one hetero atom of which is a nitrogen atom and the remaining ring atoms being at least one carbon and optionally sulfur or oxygen, with the proviso that W cannot be substituted or unsubstituted isoxazolyl, and with the further proviso that when Z is 2-chloro-4-methoxyphenyl, X is --O--, Q is C.sub.5 -C.sub.7 alkanediyl and Y is a bond, W is not imidazolyl substituted at positions 2, 4 and 5 with 1-3 substituents independently selected from the group consisting of hydrogen, hydroxyloweralkyl, nitro, loweralkoxycarbonyl, lower alkyl and amino methylene; W' is divale W. The compound is have antiviral activity, antiinflammatory activity and are PAF inhibitors.
所公开的发明是由以下式子所表示的化合物及其药学上可接受的酸盐:##STR1## 其中每个Z独立地是四叔丁基、苯基、萘基或金刚烷基;取代苯基,其中取代基是卤素、较低的烷氧基、苯氧基、腈、硝基、苯基磺酰基、较低的烷基磺酰基、噁唑-2-基、较低的烷酰基、苯酰基、较低的烷氧羰基、较低的烷基、较低的烷基硫、苯基、苯胺基硫酰基或较低的烷基氨基硫酰基,羟肟较低烷基羟基较低烷基或羰基;或者是含有至少一个氮原子的4或6元取代或未取代的杂环环,其余环成员至少为一个碳原子,可选择含有硫或氧,X和Y各自独立地是一个键,##STR2## 每个Q独立地是取代或未取代的双价直链或支链较低烷二基、较低烷二基-环辛二基-较低烷二基、较低烯二基、较低炔二基、苯撑、二氢呋喃二基、较低烷二基-二氢呋喃二基-较低烷二基、四氢呋喃二基、四氢吡喃二基、较低烷二基-四氢吡喃二基-较低烷二基或较低烷二基-四氢呋喃二基-较低烷二基;W是取代或未取代的单价芳基或含有4至10个环原子的杂环单环或融合环,其中至少一个杂原子是氮原子,其余环原子至少为一个碳原子,可选择硫或氧,但W不能是取代或未取代的异噁唑基。另外,当Z为2-氯-4-甲氧基苯基,X为--O--,Q为C.sub.5-C.sub.7烷二基,Y为一个键时,W不能是在2,4和5位取代了1-3个独立选择的来自羟基较低烷基、硝基、较低烷氧羰基、较低烷基和氨基亚甲基的取代基的咪唑基;W'是双价W。该化合物具有抗病毒活性、抗炎活性和PAF抑制剂活性。